|
|
Docu-menta >
Investigación Básica >
Artículos de Investigación Básica >
Por favor, use este identificador para citar o enlazar este ítem:
http://documenta.ciemat.es/handle/123456789/5451
|
| Título : | Identification of two rare and novel large deletions in ITGB4 gene causing epidermolysis bullosa with pyloric atresia |
| Autor : | Mencía, A García, M García, E Llames, S Charlesworth, A de Lucas, R Vicente, A Trujillo-Tiebas, MJ Coto, P Costa, M Vera, A López-Pestaña, A Murillas, R Meneguzzi, G Jorcano, JL Conti, CJ Escámez-Toledano, MJ del Río, M |
| Palabras clave : | ITGB4 mutation Epidermolysis bullosa genodermatoses inherited skin diseases pyloric atresia |
| Fecha de publicación : | abr-2016 |
| Editorial : | Exp Dermatol. |
| Citación : | Exp Dermatol. 2016 Apr;25(4):269-74. |
| Resumen : | Epidermolysis bullosa with pyloric atresia (EB-PA) is a rare autosomal recessive hereditary disease with a variable prognosis from lethal to very mild. EB-PA is classified into Simplex form (EBS-PA: OMIM #612138) and Junctional form (JEB-PA: OMIM #226730), and it is caused by mutations in ITGA6, ITGB4 and PLEC genes. We report the analysis of six patients with EB-PA, including two dizygotic twins. Skin immunofluorescence epitope mapping was performed followed by PCR and direct sequencing of the ITGB4 gene. Two of the patients presented with non-lethal EB-PA associated with missense ITGB4 gene mutations. For the other four, early postnatal demise was associated with complete lack of β4 integrin due to a variety of ITGB4 novel mutations (2 large deletions, 1 splice-site mutation and 3 missense mutations). One of the deletions spanned 278 bp, being one of the largest reported to date for this gene. Remarkably, we also found for the first time a founder effect for one novel mutation in the ITGB4 gene. We have identified 6 novel mutations in the ITGB4 gene to be added to the mutation database. Our results reveal genotype-phenotype correlations that contribute to the molecular understanding of this heterogeneous disease, a pivotal issue for prognosis and for the development of novel evidence-based therapeutic options for EB management. |
| URI : | http://documenta.ciemat.es/handle/123456789/5451 |
| Aparece en las colecciones: | Artículos de Investigación Básica
|
Los ítems de Docu-menta están protegidos por una Licencia Creative Commons, con derechos reservados.
|